tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ashwani Verma, 76 are a BUY (74.51%), 23 are a HOLD (22.55%), 3 are a SELL (2.94%).
Analyst Ashwani Verma, currently employed at UBS, carries an average stock price target met ratio of 54.4% that have a potential upside of 27.99% achieved within 155 days.
Ashwani Verma’s has documented 206 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 14-Oct-2025.
Analyst best performing recommendations are on ACLX (ARCELLX).
The best stock recommendation documented was for ACLX (ARCELLX) at 10/17/2023. The price target of $52 was fulfilled within 30 days with a profit of $16.84 (47.9%) receiving and performance score of 15.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$132
$0.13 (0.10%)
$100
8 months 2 days ago
(23-Feb-2025)
10/11 (90.91%)
$3.43 (2.67%)
292
Hold
$100
8 months 5 days ago
(20-Feb-2025)
21/22 (95.45%)
$-27.19 (-21.38%)
170
Hold
$132
$0.13 (0.10%)
$87
8 months 21 days ago
(04-Feb-2025)
8/9 (88.89%)
$4.97 (3.91%)
221
Hold
$132
$0.13 (0.10%)
$113
8 months 25 days ago
(30-Jan-2025)
12/13 (92.31%)
$4.92 (3.87%)
738
Buy
$132
$0.13 (0.10%)
$89
8 months 29 days ago
(26-Jan-2025)
10/11 (90.91%)
$4.79 (3.77%)
39
Which stock is Ashwani Verma is most bullish on?
Which stock is Ashwani Verma is most reserved on?
What Year was the first public recommendation made by Ashwani Verma?
